This fact sheet describes PATH’s efforts to advance new and better vaccines against meningococcal meningitis and strengthen the global toolkit against this deadly disease. It details work across multiple efforts, including the development and distribution of MenAfriVac®, the vaccine that has virtually eliminated meningitis A wherever it has been introduced; and MenFive®, the groundbreaking multivalent meningococcal conjugate vaccine that has the potential to eliminate epidemic meningitis in Africa, once and for all.